Bone Marrow Transplants for Leukemia

Leukaemia, a formidable challenge faced by many, demands innovative and effective treatments. Among these, a Bone Marrow Transplant (BMT) for leukaemia stands out as a crucial option, potentially offering hope and a new lease on life for patients battling this relentless disease. Understanding leukaemia and bone marrow transplant, including the role of stem cells and the type of bone marrow transplant for leukaemia, is vital for patients and caregivers alike. Doctors meticulously examine every aspect of the BMT leukaemia treatment, from the stringent selection criteria to the final stages of recovery.

This comprehensive blog illuminates the significance of BMT for leukaemia treatment as a pivotal strategy in the fight against leukaemia, delineating the step-by-step process that characterises this complex treatment option.

What is Bone Marrow Transplant (BMT)?

A bone marrow transplant (BMT), or stem cell transplant, is a medical procedure that involves infusing healthy blood-forming stem cells into the patient’s body to replace compromised bone marrow that is not producing enough healthy blood cells. These transplanted stem cells find their way to the marrow, where they begin producing new, healthy blood cells.

BMT is a specialised therapy for patients with certain cancers or other diseases. It involves taking healthy stem cells, typically found in the bone marrow, filtering them, and infusing them into the patient’s body.

Types of Leukaemia Treated with BMT

BMT has been successfully used to treat various diseases, including leukaemia, lymphomas, aplastic anaemia, immune deficiency disorders, and some solid tumour cancers. Specifically, BMT can benefit people with acute leukaemia, chronic leukaemia, Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, and multiple myeloma.

Why BMT is Effective

The goal of a BMT is to cure many blood diseases and cancers. In situations where chemotherapy or radiation therapy will permanently damage or destroy a person’s bone marrow stem cells in order to cure cancer, doctors may advise a stem cell transplant. By replacing unhealthy, immature blood cells with healthy ones, BMT can control or cure the disease, extend life, and improve the patient’s quality of life.

How Bone Marrow Transplant Works: Step-by-Step Process

The bone marrow transplant (BMT) process involves several key steps to ensure the successful replacement of diseased, damaged, or compromised bone marrow with healthy stem cells. Here’s a step-by-step overview:

A. Stem Cell Harvesting:

• The surgeon collects stem cells from either the patient (autologous transplant) or a matched donor (allogeneic transplant).
• For autologous transplants, stem cells are typically harvested from the patient’s bloodstream or bone marrow before conditioning treatment.
• In peripheral blood stem cell harvesting, the patient receives granulocyte colony-stimulating factor (G-CSF) injections to stimulate stem cell production and mobilise them into the bloodstream.
• Doctors collect the stem cells through a process called apheresis. During apheresis, they remove the patient’s blood, filter out the stem cells, and return the remaining blood components to the patient.
• Alternatively, stem cells can be extracted directly from the bone marrow through a surgical procedure called a bone marrow harvest.
• Doctors collect stem cells from the donor’s blood or bone marrow for allogeneic transplants.

B. Conditioning Treatment:

• Before the transplant, the patient undergoes conditioning therapy, which involves high-dose chemotherapy or radiation therapy.
• The conditioning regimen aims to suppress the patient’s immune system, create space in the bone marrow for the new stem cells, and eliminate any remaining cancer cells.
• Cyclophosphamide and busulfan are common chemotherapy drugs used in conditioning, but the specific regimen depends on the patient’s condition and overall health.

C. Transplant Procedure:

• Once conditioning is complete, the patient receives the harvested stem cells through an intravenous (IV) infusion, typically through a central venous catheter.
• These infused stem cells then travel to the patient’s bone marrow, where they start generating new, healthy blood cells over the next few weeks.

D. Post-Transplant Recovery:

• After the transplant, the patient remains in the hospital for several weeks to monitor for complications and allow the new stem cells to engraft (establish themselves in the bone marrow).
• During this time, the patient may experience side effects such as fatigue, nausea, and diarrhoea, as well as an increased possibility of infections due to a weakened immune system.
• Regular blood transfusions and supportive care, including antibiotics and growth factors, may be necessary until the new bone marrow starts producing sufficient blood cells.
• Once the patient is stable or their blood counts recover, they can be discharged from the hospital, but close monitoring and follow-up appointments will continue for an extended period.

It’s important to note that the recovery process can take several months, and the patient’s immune system may remain compromised during this time, requiring precautions to prevent infections, says “Dr. Anand Kumar N.”

Side Effects and Risks of Bone Marrow Transplant

Bone marrow transplants (BMTs) are complex procedures that carry significant risks and potential side effects, such as:

Short-term Side Effects

The initial phase following a BMT can be particularly challenging, with patients experiencing various short-term side effects:

• Mucositis: After chemotherapy, the patient may experience oral mucosal inflammation or soreness, which can make it painful to eat and drink. This condition usually resolves within a few weeks after treatment.
• Nausea and Vomiting: Chemotherapy drugs used in the conditioning regimen can cause severe nausea and vomiting. Anti-nausea medications are typically administered to prevent or manage these symptoms.
• Increased Possibility of Infections: Due to a weakened immune system, patients are highly susceptible to serious bacterial, viral, & fungal infections during the first six weeks after BMT until the new stem cells start producing white blood cells (engraftment).
• Low Blood Cell Counts: After the conditioning treatment, patients may have low red blood cell levels (anaemia), platelets (increased risk of bleeding), and white blood cells (increased infection risk). Doctors may provide blood transfusions and supportive care during this period.
• Diarrhoea: Various treatment modalities during this procedure, including chemotherapy, radiation, infections, or graft-versus-host disease (GvHD), can lead to severe diarrhoea, requiring prompt medical attention and treatment.
• Fatigue and Weakness: Patients often feel extremely tired and run down, especially during the second and third weeks when blood cell counts are at their lowest. This fatigue can persist for an extended period after the transplant.

Long-term Risks

While the short-term side effects are challenging, there are also potential long-term risks associated with BMTs:

• Infertility: High-dose chemotherapy and total body irradiation used in the conditioning regimen can cause permanent infertility in most patients, affecting their ability to conceive or father a child naturally.
• Graft-versus-Host Disease (GvHD): In allogeneic transplants (using donor stem cells), the donor’s immune cells may attack the recipient’s body tissues, leading to complications such as diarrhoea, weight loss, jaundice, skin rashes, and breathing difficulties. GVHD can occur within a few months or even years after the transplant.
• Hepatic Veno-Occlusive Disease (VOD): A serious condition where tiny veins and blood vessels inside the liver become blocked, primarily seen in allogeneic transplants involving certain conditioning drugs like busulfan or melphalan.
• Graft Failure: In some cases, the body may not accept the new stem cells, leading to graft failure, which is more common when the patient and donor are not well-matched or when T-cells have been removed from the stem cells.

Management of Side Effects

While the side effects and risks of BMTs can be significant, medical teams are equipped to manage and mitigate these complications. Preventive measures, prompt treatment, and close monitoring can help alleviate the severity of side effects and improve patient outcomes. Patients must communicate concerns or symptoms with their medical team to receive appropriate care and support throughout the BMT process.

Conclusion

Bone Marrow Transplant (BMT) emerges as a critical, albeit intricate, treatment option for leukaemia, offering a significant chance for recovery and extended survival. By meticulously examining the entire process—from stem cell harvesting to post-transplant recovery—this guide has highlighted the profound potential and the inherent challenges of BMT. The importance of informed decision-making, supported by robust communication between patients, caregivers, and doctors, cannot be overstated. The journey through BMT is complex, with its impact extending well into long-term quality-of-life considerations. As we continue to advocate for and support ongoing research and advancements, the medical community’s collective efforts are crucial in refining this treatment. Enhancing its efficacy while minimising risks remains a primary goal, providing leukaemia patients with a treatment path and a beacon of hope for a brighter, healthier future.

You are welcome to discuss this procedure with our experienced doctors. Book your appointment now.

Frequently Asked Question

What is BMT leukaemia?

BMT, or bone marrow transplant (also called stem cell transplant), is a treatment for leukaemia where your bone marrow, which makes blood cells, is replaced with healthy stem cells. These stem cells can come from you (autologous) or a donor (allogeneic).

What is the success rate of bone marrow transplants for leukaemia?

Bone marrow transplants can be very effective for leukaemia, especially when leukaemia is in remission. Success rates can vary with age, health condition, and leukaemia type but can range from 55-70% for allogeneic transplants in younger patients. It’s a complex procedure with risks, so it’s always discussed as part of a personalised treatment plan.